Top

LATEST PUBLICATIONS



FDA Approves Radicava ORS (edaravone) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

May 13, 2022

Category: FDA, Regulations

Mitsubishi Tanabe Pharma Corporation (MTPA) today announced the U.S. Food and Drug Administration (FDA) has approved Radicava ORS (edaravone), the oral form of edaravone, for the treatment of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease that currently has no cure […]


Record-breaking 2021 revenue shows there’s more to Swiss biotech sector than Roche, Novartis

May 4, 2022

Category: Biotech, Industry

Swiss biotechs saw record-breaking revenue and R&D investment in 2021, which the industry hopes will lead people to look beyond homegrown giants like Roche and Novartis. The new findings, outlined by the Swiss Biotech Association in its latest annual report […]


3 Reasons Why Cloud Contact Centres Are the Next Step in Customer Success

April 25, 2022

Category: Editorial

At the same time that the implications of the global pandemic have created difficulties for many, they have also sparked an opportunity for growth and change.  One key area that has continued to evolve even as we return to a […]


Mergers and Acquisitions

Pfizer to Acquire Biohaven Pharmaceuticals for $11.6 Billion

May 10, 2022

Via: Contract Pharma

Pfizer and Biohaven Pharmaceuticals have entered into an agreement under which Pfizer will acquire Biohaven, the maker of NURTEC ODT, a dual-acting migraine therapy approved for both acute treatment and episodic prevention of migraine in adults. Pfizer will pay approximately […]


FDA, Regulations

With spotlight on FDA, Congress weighs reforms to accelerated drug approvals

May 10, 2022

Via: Biopharma Dive

Over the past few years, the Food and Drug Administration has come increasingly under scrutiny for its program to grant speedy approvals to drugs that show early signs of benefiting patients with life-threatening diseases. These so-called accelerated approvals have ushered […]


Cell and Gene Therapy, Industry

LogicBio’s sun and shares rise again after FDA releases clinical hold on pediatric genome editing therapy

May 9, 2022

Via: FierceBiotech

The sun and shares are rising again at LogicBio after the FDA lifted a clinical hold on a genome editing therapy for children with a rare disorder. Shares of the Lexington, Massachusetts-based biotech were sent skyward by 60% as the […]


Cell and Gene Therapy, Industry

Investors take root in Aspen Neuroscience’s customized cell therapy as $147.5M round closes

May 9, 2022

Via: FierceBiotech

Aspen Neuroscience, a biotech developing the first autologous neuron replacement for Parkinson’s disease, is seeing double, as investors have flooded the company’s series B with $147.5 million following an initial $70 million round two years ago. The private neurodegenerative disease […]


Biotech, Industry

ALSA Ventures, Lonza Partner to Provide Biotech Support & Services

May 9, 2022

Via: Contract Pharma

ALSA Ventures, a London based European biotech investment firm, and Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, have entered a collaboration agreement to help develop and manufacture biologics and small molecule drug candidates […]